Skip to main content
Aller à la page d’accueil de la Commission européenne (s’ouvre dans une nouvelle fenêtre)
français fr
CORDIS - Résultats de la recherche de l’UE
CORDIS

Development of a very rapid diagnostic test for malaria, based on break-through detection technology and new biomarkers of infection.

Objectif

The overall project objective is to develop and bring to market a very rapid diagnostic test (V-RDT) for malaria, based on break-through detection technology and particularly relevant biomarkers of infection.

Our ambition is for our diagnostic device to become the reference technology in all malaria endemic areas.

A key advantage of our approach lies in the combination of an innovative detection device with novel biomarkers that should significantly improve the quality of testing and the ability to implement mass testing campaigns.

Our device is expected to overcome most shortcomings identified in devices currently on the market. The expected added value of our proposed diagnostic device to users is multiple including:
• Rapidity: 1 minute vs. 15-20 minutes required for most current tests. This is a major competitive advantage for cross-sectional testing necessary for eradication efforts;
• High sensitivity including quantitative evaluations (picomolar detection);
• Several simultaneous measures to distinguish parasite species (P. falciparum / P. vivax);
• Infection parameters (parasite density and antibody response): the comprehensive nature of our diagnostic read-outs provide information on prognosis and/or therapeutic response in addition to simple yes/no diagnoses; and
• Functional and reliable in expected field conditions (tropical environments). .

Champ scientifique (EuroSciVoc)

Ce projet n'a pas encore été classé par EuroSciVoc.
Proposez les domaines scientifiques qui vous semblent les plus pertinents et aidez-nous à améliorer notre service de classification.

Programme(s)

Thème(s)

Régime de financement

SME-1 - SME instrument phase 1

Voir tous les projets financés dans le cadre de ce programme de financement

Appel à propositions

(s’ouvre dans une nouvelle fenêtre) H2020-SMEInst-2014-2015

Voir tous les projets financés au titre de cet appel

Coordinateur

VAXIMAX
Contribution nette de l'UE
€ 50 000,00
Adresse
4 RUE PIERRE FONTAINE CAMPUS 3
91058 Evry
France
PME
Oui
Région
Ile-de-France Ile-de-France Essonne
Type d’activité
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Liens
Coût total
€ 71 429,00

Participants (1)